Northwestern Mutual Wealth Management
CRBP icon

Northwestern Mutual Wealth Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$11 – 3717
2025
Q1 		$11 Buy
+2
New +$18 ﹤0.01% 3621
2022
Q4 		– Hold
0
– – – 3345
2022
Q3 		– Hold
0
– – – 3164
2022
Q2 		– Hold
0
– – – 3219
2022
Q1 		– Hold
0
– – – 3150
2020
Q3 		– Sell
-5
Closed -$1K – 2548
2020
Q2 		$1K Buy
+5
New +$1.01K ﹤0.01% 2270

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Northwestern Mutual Wealth Management's CRBP Position: Q2 2025 in Review

Northwestern Mutual Wealth Management sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 2 shares — an estimated $11 sold.

Northwestern Mutual Wealth Management first reported a position in CRBP in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q2 2020. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Northwestern Mutual Wealth Management reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2 Corbus Pharmaceuticals shares in Q2 2025, an estimated $11.
  • Northwestern Mutual Wealth Management first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Corbus Pharmaceuticals position peaked at $1K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.